Cite

HARVARD Citation

    Fife, D. et al. (2022). Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations. Neuropsychopharmacology reports. 42 (3), pp. 347-351. [Online]. 
  
Back to record